News Snapshot:
Science Chinese COVID-19 vaccine CoronaVac shows 78 percent efficacy in Phase 3 trials in Brazil Turkey, which also helped carry out CoronaVac's Phase 3 tests, said the vaccine had shown the effectiveness of 91.25 percent in its trials. Agence France-Presse Jan 08, 2021 12:43:57 IST Chinese-developed Covid-19 vaccine CoronaVac showed at least 78-percent effectiveness in final-stage clinical trials in Brazil, officials announced Thursday, saying they would apply for emergency approval from the Brazilian regulatory agency to begin a vaccination campaign. "This is a historic day, a day of hope," Sao Paulo state Governor Joao Doria told a news conference announcing...
